FEG
FBT icon

Financial Enhancement Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$943K Buy
5,658
+105
+2% +$17.5K 0.13% 92
2025
Q1
$864K Buy
5,553
+667
+14% +$104K 0.13% 84
2024
Q4
$851K Buy
4,886
+1,189
+32% +$207K 0.13% 80
2024
Q3
$573K Sell
3,697
-1,227
-25% -$190K 0.11% 96
2024
Q2
$831K Buy
4,924
+26
+0.5% +$4.39K 0.13% 76
2024
Q1
$722K Buy
4,898
+163
+3% +$24K 0.12% 87
2023
Q4
$715K Buy
4,735
+755
+19% +$114K 0.13% 84
2023
Q3
$580K Buy
3,980
+69
+2% +$10.1K 0.11% 95
2023
Q2
$597K Buy
3,911
+214
+6% +$32.7K 0.11% 94
2023
Q1
$573K Sell
3,697
-40
-1% -$6.2K 0.11% 96
2022
Q4
$603K Sell
3,737
-23
-0.6% -$3.71K 0.12% 93
2022
Q3
$496K Buy
3,760
+147
+4% +$19.4K 0.11% 78
2022
Q2
$490K Buy
3,613
+1,745
+93% +$237K 0.11% 78
2022
Q1
$279K Buy
1,868
+50
+3% +$7.47K 0.05% 92
2021
Q4
$294K Buy
1,818
+187
+11% +$30.2K 0.05% 93
2021
Q3
$271K Buy
1,631
+172
+12% +$28.6K 0.05% 86
2021
Q2
$252K Buy
1,459
+117
+9% +$20.2K 0.05% 82
2021
Q1
$215K Buy
1,342
+7
+0.5% +$1.12K 0.04% 86
2020
Q4
$224K Buy
1,335
+2
+0.2% +$336 0.05% 92
2020
Q3
$210K Sell
1,333
-20
-1% -$3.15K 0.05% 88
2020
Q2
$227K Buy
1,353
+18
+1% +$3.02K 0.06% 89
2020
Q1
$175K Buy
1,335
+1,313
+5,968% +$172K 0.05% 93
2019
Q4
$3K Sell
22
-28
-56% -$3.82K ﹤0.01% 229
2019
Q3
$6K Sell
50
-32,480
-100% -$3.9M ﹤0.01% 216
2019
Q2
$4.58M Buy
32,530
+7,870
+32% +$1.11M 1.34% 27
2019
Q1
$3.72M Sell
24,660
-18,873
-43% -$2.85M 1.13% 30
2018
Q4
$6.9M Buy
43,533
+37
+0.1% +$5.86K 2.17% 13
2018
Q3
$6.89M Buy
43,496
+2,096
+5% +$332K 2.17% 13
2018
Q2
$5.8M Buy
+41,400
New +$5.8M 2% 17
2017
Q1
Sell
-51,089
Closed -$4.64M 65
2016
Q4
$4.64M Buy
51,089
+47,821
+1,463% +$4.35M 2.4% 14
2016
Q3
$326K Sell
3,268
-650
-17% -$64.8K 0.18% 45
2016
Q2
$350K Sell
3,918
-3,309
-46% -$296K 0.21% 35
2016
Q1
$633K Sell
7,227
-182
-2% -$15.9K 0.41% 32
2015
Q4
$837K Sell
7,409
-304
-4% -$34.3K 0.51% 33
2015
Q3
$781K Sell
7,713
-22,336
-74% -$2.26M 0.51% 34
2015
Q2
$3.73M Buy
+30,049
New +$3.73M 2.35% 13